Ronald J. Sokol, MD
University of Colorado Denver
H-index: 98
North America-United States
Top articles of Ronald J. Sokol, MD
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases
Hepatology Communications
2024/1/1
LRH-1 agonist DLPC through STAT6 promotes macrophage polarization and prevents parenteral nutrition-associated cholestasis in mice
Hepatology
2024/5/1
Establishing Neonate-specific Prognostic Markers in Acute Liver Failure: Admission Alpha Fetoprotein and Novel nALF Scores Predict Patient Outcomes
The Journal of Pediatrics
2024/4/29
Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort
Hepatology
2024/3/6
Reply to:“Cytomegalovirus infection in patients with biliary atresia—further questions and possible solutions”
Hepatology Communications
2024/2/1
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance
Hepatology Communications
2023/12/1
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease
Hepatology
2023/2/1
Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor
Hepatology
2023/12/1
Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury
Hepatology Communications
2023/1/1
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease
Hepatology Communications
2023/11/1
Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition
Plos one
2023/8/30
Cytomegalovirus in biliary atresia is associated with increased pretransplant death, but not decreased native liver survival
Hepatology Communications
2023/8/1
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
Jhep Reports
2023/8/1
Publisher Correction: Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice
Scientific Reports
2023/7/19
Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children
Hepatology Communications
2023/6/1
Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice
Scientific Reports
2023/5/12
Real-world evidence of neutralizing monoclonal antibodies for preventing hospitalization and mortality in COVID-19 outpatients
Chest
2023/5/1
Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis
Hepatology Communications
2023/3/1
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy
Hepatology
2023/3/1
Genotype-phenotype relationships of truncating mutations, p. E297G and p. D482G in bile salt export pump deficiency
JHEP Reports
2023/2/1
Co-Authors
